Kerala Ayurveda Ltd

Kerala Ayurveda Ltd

₹ 194 -4.55%
29 May - close price
About

Incorporated in 1945, Kerala Ayurveda Ltd is engaged In Ayurvedlc services and products[1]

Key Points

Business Overview:[1]
Company manufactures Ayurveda products and deals in Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and Services, cultivation of Ayurveda herbs, and maintaining a herbarium of medicinal plants

  • Market Cap 252 Cr.
  • Current Price 194
  • High / Low 625 / 150
  • Stock P/E
  • Book Value 8.56
  • Dividend Yield 0.00 %
  • ROCE -9.77 %
  • ROE -161 %
  • Face Value 10.0

Pros

  • Debtor days have improved from 51.1 to 38.4 days.
  • Promoter holding has increased by 2.47% over last quarter.

Cons

  • Stock is trading at 22.7 times its book value
  • Company has low interest coverage ratio.
  • Promoter holding is low: 35.6%
  • Company has a low return on equity of -85.2% over last 3 years.
  • Promoter holding has decreased over last 3 years: -25.9%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
23.84 23.78 25.03 26.32 32.03 27.47 30.41 31.13 31.32 28.61 34.84 32.96 34.74
23.15 22.25 24.49 25.31 26.58 26.67 24.88 32.32 41.46 32.79 39.79 34.47 41.84
Operating Profit 0.69 1.53 0.54 1.01 5.45 0.80 5.53 -1.19 -10.14 -4.18 -4.95 -1.51 -7.10
OPM % 2.89% 6.43% 2.16% 3.84% 17.02% 2.91% 18.18% -3.82% -32.38% -14.61% -14.21% -4.58% -20.44%
0.11 0.16 0.77 0.23 -0.86 0.22 0.64 0.23 0.73 9.47 1.70 1.13 1.91
Interest 1.25 1.51 0.65 0.61 3.26 0.46 0.72 0.43 2.48 0.82 2.58 2.84 1.10
Depreciation 0.23 0.33 0.32 0.34 1.15 0.36 1.98 0.72 1.92 1.65 0.99 1.15 1.69
Profit before tax -0.68 -0.15 0.34 0.29 0.18 0.20 3.47 -2.11 -13.81 2.82 -6.82 -4.37 -7.98
Tax % -170.59% 106.67% 100.00% 368.97% -194.44% -125.00% -4.90% 27.96% 11.30% 27.66% -6.74% 5.26% -7.39%
0.47 -0.30 0.00 -0.79 0.53 0.46 3.65 -2.70 -15.38 2.03 -6.36 -4.60 -7.39
EPS in Rs 0.17 -0.34 -0.12 -0.90 0.22 0.27 2.84 -2.40 -12.92 1.65 -5.26 -3.69 -5.97
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
39 46 50 59 59 77 62 80 93 108 126 131
33 38 43 51 54 69 61 71 91 100 131 149
Operating Profit 6 8 7 8 5 7 1 10 3 9 -5 -18
OPM % 15% 16% 14% 14% 9% 10% 1% 12% 3% 8% -4% -14%
0 0 0 0 1 0 0 1 3 0 2 14
Interest 2 2 1 2 3 2 6 7 5 6 4 7
Depreciation 1 2 2 2 1 1 1 1 1 2 5 5
Profit before tax 3 4 4 4 3 5 -7 3 -1 1 -12 -16
Tax % 21% 33% 22% 31% 19% 11% -28% 15% -23% 185% 14% -0%
3 3 3 3 3 4 -5 2 -0 -1 -14 -16
EPS in Rs 2.24 2.56 2.90 2.66 2.31 3.69 -4.59 2.24 -0.85 -0.47 -11.60 -12.74
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 11%
5 Years: 16%
3 Years: 12%
TTM: 4%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -19%
Stock Price CAGR
10 Years: 13%
5 Years: 28%
3 Years: 18%
1 Year: -53%
Return on Equity
10 Years: -36%
5 Years: -69%
3 Years: -85%
Last Year: -161%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 11 11 11 11 11 11 11 11 11 12 12 13
Reserves -19 -17 -4 -3 -7 -3 -7 -4 -5 7 -3 -2
70 69 56 75 62 64 77 70 72 76 71 86
11 11 17 20 27 31 34 34 37 38 49 41
Total Liabilities 73 73 81 103 92 103 114 110 115 133 129 138
33 34 34 32 33 33 33 44 46 41 47 50
CWIP 0 0 6 11 12 14 14 4 7 7 9 8
Investments 0 0 0 0 0 0 0 0 0 0 0 0
40 39 41 59 47 56 68 62 61 85 73 81
Total Assets 73 73 81 103 92 103 114 110 115 133 129 138

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 6 4 -10 12 5 7 -0 10 -1 5 -24
-0 -3 -3 -3 -3 -4 -1 -2 -7 -0 -15 -5
2 -2 0 17 -12 1 6 -13 -1 20 -9 32
Net Cash Flow 2 -0 1 4 -2 2 12 -16 2 18 -19 3
Free Cash Flow -0 2 3 -16 10 2 6 -3 4 -2 -8 -30
CFO/OP 8% 73% 62% -120% 251% 71% 885% -5% 390% 1% -138% 136%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 35 33 35 34 43 51 61 61 51 59 56 38
Inventory Days 287 227 319 338 311 313 268 254 227 205 208 200
Days Payable 150 100 112 125 117 162 149 168 137 114 93 129
Cash Conversion Cycle 172 160 242 247 236 202 179 147 141 149 171 109
Working Capital Days -131 -103 -213 -63 -24 -19 -99 -118 -81 -172 -147 -162
ROCE % 8% 9% 9% 9% 6% 9% -0% 11% 2% 8% -9% -10%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Permanent Employees
Count ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Service Revenue Weightage (as % of Turnover)
% ・Standalone data
Herbarium Plant Varieties
Count ・Standalone data
Number of Certified Students / Alumni (USA Academy)
Count
Number of Major Distribution Depots
Count ・Standalone data
Number of SKUs
Count
R&D Expenditure as % of Turnover
% ・Standalone data
India E-commerce Revenue Growth
%
Number of Treatment Centers and Wellness Clinics
Count
R&D Expenditure (Percentage of Turnover)
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

4 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
61.52% 61.52% 63.44% 58.58% 58.58% 58.58% 58.58% 58.58% 37.83% 33.14% 33.14% 35.60%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.22% 0.17%
0.05% 0.05% 0.05% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%
38.44% 38.43% 36.51% 41.37% 41.39% 41.38% 41.37% 41.37% 62.12% 66.81% 66.59% 64.20%
No. of Shareholders 7,7807,8558,4288,5818,6559,0529,0099,0749,4019,9389,95210,225

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents